GSK struggles with more competition in finding drug deals

09/24/2009 | Bloomberg

Companies willing to pay high prices for novel treatments are hampering GlaxoSmithKline's efforts to boost its pipeline through drug acquisitions, said Moncef Slaoui, GSK's head of research. Slaoui said the strategy by "desperate" rival drugmakers will not be used by GSK, which plans to announce next month its expansion into medicines for rare diseases.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX